University of New England, New South Wales, Australia.
J Psychosoc Oncol. 2010;28(6):644-65. doi: 10.1080/07347332.2010.516810.
To determine the presence and nature of variability in anxiety and depression in patients with prostate cancer (PCa) over 3 years following diagnosis, 442 patients with PCa completed standardized anxiety and depression inventories via survey between 1 and 36 months after receiving their initial diagnosis. Data were analyzed from a series of 3-month cohorts, and results indicated that total scores and incidence of clinically significant anxiety and depression varied over time, but that this variability was restricted to specific subfactors of anxiety and depression. Provision of effective psychological treatment to patients with PCa is discussed.
为了确定前列腺癌（PCa）患者在诊断后 3 年内焦虑和抑郁的存在和性质，442 名 PCa 患者在接受初始诊断后 1 至 36 个月期间通过调查完成了标准化的焦虑和抑郁评估。对一系列 3 个月的队列进行了数据分析，结果表明，总评分和临床显著焦虑和抑郁的发生率随时间变化，但这种变化仅限于焦虑和抑郁的特定亚因素。讨论了为 PCa 患者提供有效心理治疗的问题。
